In all cohorts combined, the CCND1 polymorphism did not show statistically significant associations to risk of colorectal cancer (odds ratio (OR), 1.04; 95% CI, 0.82–1.32) or adenoma (OR, 0.96; 95% CI, 0.77–1.18). Here, CCND1 is linked to colorectal cancer.